FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Fidaxomicin

Sort
E.g., 2013-06-19
E.g., 2013-06-19
Enter a comma separated list of user names.

OPTR, PWRM, FSP, FRG, WAC, - PennyToBuck.com Stock Highlights! Optimer Pharmaceuticals, Power3 Medical Products, Franklin Street
Posted by PennyToBuck on April 3rd, 2011

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR)

Optimer Pharmaceuticals, Inc. is focus on medicines that make a significant difference in the lives of patients and reduce the burden of disease.

Clostridium difficile is a bacterium that can cause symptoms ranging from diarrhea to life-threatening inflammation of the colon.

Read More
comment 0
Share
Tags:
Inc., pwrm, pwrm.ob, Power3 Medical Products, Optimer Pharmaceuticals, AMEX:WAC, walter, AMEX:FRG, NASDAQ:OPTR, Fronteer, AMEX:FSP, Fidaxomicin, Franklin Street

OPTR, PWRM, SA, MCF, MEG, - CRWESelect.com Stock News! (Optimer Pharmaceuticals Video Included Inside), Power3 Medical Products
Posted by CRWESelect Stoc... on April 3rd, 2011

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR)

Optimer Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing innovative hospital specialty products that have a positive impact on society.

Read More
comment 0
Share
Tags:
MEG, pwrm, seabridge gold, Power3 Medical Products, nuropro, media general, nyse:meg, power3, AMEX:SA, OPTR, Optimer Pharmaceuticals, NASDAQ:OPTR, Clostridium difficile infection, Fidaxomicin, diarrhea, AMEX:MCF, Contango Oil & Gas Co., Food and Drug Administration, MCF, S.A.

OPTR, ESLR, PWRM, EXAS, EGI - Stock Report, News, and Must Watch Video!! From PennyOmega.com
Posted by pennylynnomega on April 3rd, 2011

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI.

Read More
comment 0
Share
Tags:
gold, ESLR, Evergreen Solar, copper, cancer, stem cell, Alzheimer's, pwrm.ob, breast cancer, nuropro, Power 3 Medical, neurodegenerative disease, diagnostic tests, protein biomarkers, exact sciences, nasdaq:exas, ALS, patents, Rozetta-Cell, Entree Gold, Nasdaq:ESLR, bc serapro, Parkinsons, solar power products, OPTR, Optimer Pharmaceuticals, CDI, colorectal cancer, EXAS, EGI, mineral exploration company, Parkinsons disease, Lou Gehrigs Disease, otcbb:pwrm, Ivanhoe Mines, NASDAQ:OPTR, Helen Parks, Clostridium difficile infection, mortality rate, complications, Society for Healthcare Epidemiology of America, Fidaxomicin, antibiotic, colon inflammation, diarrhea, COBK, String Ribbon solar panels, molecular diagnostics company, NYSE:EGI

(OPTR- Video Include!) - PWRM, JRCC, JMBA, JHX - Stock Update by Stock-Pr.com
Posted by HotStockPR on April 3rd, 2011

Stock-PR Reporting

FREE Daily Stock Alerts From Stock-PR.com

________________________________________

Read More
comment 0
Share
Tags:
biotechnology, cancer, fda, otc:pwrm, pwrm.ob, Power3 Medical Products, Alzheimers, neurodegenerative disease, diagnostic tests, protein biomarkers, Lou Gehrig's disease, power3, Parkinsons, Optimer Pharmaceuticals, clostridium difficile, bacterium, NASDAQ:JMBA, Nasdaq:JRCC, James Hardie Building Products, NYSE:JHX, NASDAQ:OPTR, Optimer, Fidaxomicin, diarrhea, hospital infection, James River Coal Company, RNA polymerase

OPTR, PWRM, SANW, SONE, SB - Companies Helping With Diseases, Plus Must Watch Video From DrStockPick.com!!
Posted by drstockpick on April 3rd, 2011

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI.

Read More
comment 0
Share
Tags:
banks, retailers, SONE, cancer, Alzheimer's, stem cells, credit unions, pwrm.ob, breast cancer, nuropro, Power 3 Medical, neurodegenerative disease, diagnostic tests, protein biomarkers, ALS, patents, S&W Seed Company, NASDAQ:SANW, SANW, NASDAQ:SONE, NYSE:SB, Safe Bulkers, SB, Rozetta-Cell, marine drybulk transportation, bc serapro, Parkinsons, Optimer Pharmaceuticals, CDI, S1, Parkinsons disease, Lou Gehrigs Disease, software products, otcbb:pwrm, NASDAQ:OPTR, Helen Parks, Clostridium difficile infection, mortality rate, complications, Society for Healthcare Epidemiology of America, Fidaxomicin, antibiotic, colon inflammation, diarrhea, alfalfa seed varieties

OPTR, PWRM, TQNT, COBK, ULU - Optimer Pharmaceuticals Helps Patients With CDI, Plus Stock News From DoubleInStocks.com!!
Posted by doubleinstocks1 on April 3rd, 2011

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) announced the presentation of information from insurance claims and survey databases highlighting the unmet need for targeted therapies to treat subpopulations at high risk of recurrence of Clostridium difficile infection (CDI). The research also presented the substantial mortality and frequent complications associated with CDI. Investigator Erik R.

Read More
comment 0
Share
Tags:
cancer, stem cell, pwrm, pwrm.ob, Helen Park, breast cancer, Power3 Medical Products, nuropro, Alzheimers, neurodegenerative disease, diagnostic tests, protein biomarkers, Rozetta Cell, ALS, patents, power3, ULU, AMEX:ULU, Uluru, bc serapro, ira goldknopf, Parkinsons, Optimer Pharmaceuticals, CDI, Nasdaq:TQNT, Lou Gehrigs Disease, otcbb:pwrm, NASDAQ:OPTR, TriQuint, Colonial, Clostridium difficile infection, mortality rate, complications, Society for Healthcare Epidemiology of America, Fidaxomicin, antibiotic, colon inflammation, diarrhea, Nasdaq:COBK, TQNT, COBK

ADVERTISE WITH US